AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionSystematic Financial Management Lp
Latest Disclosed Ownership9,300 shares
Latest Disclosed Value $ 2,022,657
Systematic Financial Management Lp ownership in 4AB / AbbVie Inc.

On May 13, 2026 - Systematic Financial Management Lp filed a 13F-HR form disclosing ownership of 9,300 shares of AbbVie Inc. (BG:4AB) valued at $2,022,657 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 9,300 shares of AbbVie Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F AbbVie COM 00287Y109 9,300 0 0.00 2,023 -4.80 0.0381
2026-02-09 2025-12-31 13F AbbVie COM 00287Y109 9,300 0 0.00 2,125 -1.35 0.0501
2025-11-13 2025-09-30 13F AbbVie COM 00287Y109 9,300 0 0.00 2,153 24.74 0.0524
2025-08-13 2025-06-30 13F AbbVie COM 00287Y109 9,300 0 0.00 1,726 -11.40 0.0461
2025-05-14 2025-03-31 13F AbbVie COM 00287Y109 9,300 0 0.00 1,949 17.92 0.0555
2025-02-14 2024-12-31 13F AbbVie COM 00287Y109 9,300 0 0.00 1,653 -10.02 0.0421
2024-11-14 2024-09-30 13F AbbVie COM 00287Y109 9,300 0 0.00 1,837 15.11 0.0468
2024-08-16 2024-06-30 13F AbbVie COM 00287Y109 9,300 0 0.00 1,595 -5.79 0.0485
2024-05-15 2024-03-31 13F AbbVie COM 00287Y109 9,300 0 0.00 1,694 17.49 0.0473
2024-02-14 2023-12-31 13F AbbVie COM 00287Y109 9,300 0 0.00 1,441 3.97 0.0428
2023-11-14 2023-09-30 13F AbbVie COM 00287Y109 9,300 0 0.00 1,386 10.70 0.0446
2023-08-14 2023-06-30 13F AbbVie COM 00287Y109 9,300 0 0.00 1,253 -15.52 0.0395
2023-05-12 2023-03-31 13F AbbVie COM 00287Y109 9,300 0 0.00 1,482 -1.33 0.0485
2023-02-15 2022-12-31 13F AbbVie COM 00287Y109 9,300 0 0.00 1,503 20.35 0.0492
2022-11-14 2022-09-30 13F AbbVie COM 00287Y109 9,300 0 0.00 1,248 -12.36 0.0455
2022-08-15 2022-06-30 13F AbbVie COM 00287Y109 9,300 0 0.00 1,424 -5.57 0.0495
2022-05-11 2022-03-31 13F AbbVie COM 00287Y109 9,300 0 0.00 1,508 19.78 0.0471
2022-02-14 2021-12-31 13F AbbVie COM 00287Y109 9,300 0 0.00 1,259 25.52 0.0373
2021-11-12 2021-09-30 13F AbbVie COM 00287Y109 9,300 0 0.00 1,003 -4.29 0.0311
2021-08-12 2021-06-30 13F AbbVie COM 00287Y109 9,300 0 0.00 1,048 4.17 0.0317
2021-05-10 2021-03-31 13F AbbVie COM 00287Y109 9,300 0 0.00 1,006 1.00 0.0368
2021-02-12 2020-12-31 13F AbbVie COM 00287Y109 9,300 0 0.00 996 22.21 0.0437
2020-11-12 2020-09-30 13F AbbVie COM 00287Y109 9,300 0 0.00 815 -10.73 0.0446
2020-08-13 2020-06-30 13F AbbVie COM 00287Y109 9,300 0 0.00 913 28.77 0.0475
2020-05-12 2020-03-31 13F AbbVie COM 00287Y109 9,300 0 0.00 709 -13.85 0.0435
2020-02-14 2019-12-31 13F AbbVie COM 00287Y109 9,300 -310 -3.23 823 13.05 0.0322
2019-11-06 2019-09-30 13F AbbVie COM 00287Y109 9,610 -16,637 -63.39 728 -61.86 0.0326
2019-07-26 2019-06-30 13F AbbVie COM 00287Y109 26,247 -3,228 -10.95 1,909 -19.62 0.0742
2019-05-03 2019-03-31 13F AbbVie COM 00287Y109 29,475 -3,533 -10.70 2,375 -21.95 0.0813
2019-02-13 2018-12-31 13F AbbVie COM 00287Y109 33,008 5,158 18.52 3,043 15.53 0.0935
2018-11-06 2018-09-30 13F AbbVie COM 00287Y109 27,850 -405 -1.43 2,634 0.61 0.0636
2018-08-08 2018-06-30 13F AbbVie COM 00287Y109 28,255 18,955 203.82 2,618 197.50 0.0640
2018-05-09 2018-03-31 13F AbbVie COM 00287Y109 9,300 0 0.00 880 -2.11 0.0195
2018-02-09 2017-12-31 13F AbbVie COM 00287Y109 9,300 0 0.00 899 8.84 0.0180
2017-11-08 2017-09-30 13F AbbVie COM 00287Y109 9,300 0 0.00 826 22.55 0.0168
2017-08-10 2017-06-30 13F AbbVie COM 00287Y109 9,300 0 0.00 674 11.22 0.0125
2017-05-11 2017-03-31 13F AbbVie COM 00287Y109 9,300 0 0.00 606 4.12 0.0107
2017-02-10 2016-12-31 13F AbbVie COM 00287Y109 9,300 0 0.00 582 -0.85 0.0092
2017-01-26 2016-09-30 13F/A-4 AbbVie COM 00287Y109 9,300 0 0.00 587 2.09 0.0082
2016-11-14 2016-09-30 13F AbbVie COM 00287Y109 9,300 586
2017-01-25 2016-06-30 13F/A-2 AbbVie COM 00287Y109 9,300 -209,640 -95.75 575 -95.40 0.0078
2016-08-09 2016-06-30 13F AbbVie COM 00287Y109 9,300 575
2016-05-11 2016-03-31 13F AbbVie COM 00287Y109 218,940 -7,077 -3.13 12,505 -6.60 0.1564
2016-02-10 2015-12-31 13F AbbVie COM 00287Y109 226,017 -41,303 -15.45 13,389 -7.94 0.1463
2015-11-06 2015-09-30 13F AbbVie COM 00287Y109 267,320 -23,784 -8.17 14,544 -25.64 0.1543
2015-08-10 2015-06-30 13F AbbVie COM 00287Y109 291,104 -48,326 -14.24 19,559 -1.57 0.1674
2015-05-11 2015-03-31 13F AbbVie COM 00287Y109 339,430 79,737 30.70 19,870 16.92 0.1569
2015-02-10 2014-12-31 13F AbbVie COM 00287Y109 259,693 -190,805 -42.35 16,994 -34.69 0.1256
2014-11-12 2014-09-30 13F AbbVie COM 00287Y109 450,498 -5,316 -1.17 26,020 1.14 0.1895
2014-08-11 2014-06-30 13F AbbVie COM 00287Y109 455,814 -62,995 -12.14 25,726 -3.53 0.1756
2014-08-11 2014-03-31 13F/A-1 AbbVie COM 00287Y109 518,809 68,896 15.31 26,666 12.24 0.1831
2014-05-15 2014-03-31 13F AbbVie COM 00287Y109 518,809 26,666
2014-08-11 2013-12-31 13F/A-2 AbbVie COM 00287Y109 449,913 189,618 72.85 23,759 104.08 0.1741
2014-02-14 2013-12-31 13F AbbVie COM 00287Y109 449,913 23,759
2014-08-11 2013-09-30 13F/A-3 AbbVie COM 00287Y109 260,295 256,895 7,555.74 11,642 8,215.71 0.0922
2013-11-12 2013-09-30 13F AbbVie COM 00287Y109 260,295 11,642
2013-08-06 2013-06-30 13F AbbVie COM 00287Y109 3,400 3,400 140 0.0012
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.